Literature DB >> 23299878

Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays.

Xing-Feng Ren1, Hong-Wei Li, Xuexun Fang, Yuqing Wu, Lincong Wang, Shuxue Zou.   

Abstract

We have developed a series of azadipeptide nitriles with different P3 groups. A triaryl meta-phenyl derivative, compound 13, was not only a potent inhibitor for cathepsin K (K(i) = 0.0031 nM), but also highly selective over both cathepsins B and S (~1000-fold). A protein-ligand docking study performed on the series provided a possible explanation why compound 13 could be significantly more potent than the others, especially compound 12 in the same series.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299878     DOI: 10.1039/c2ob26624e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  3-Cyano-3-aza-β-amino Acid Derivatives as Inhibitors of Human Cysteine Cathepsins.

Authors:  Janina Schmitz; Anna-Madeleine Beckmann; Adela Dudic; Tianwei Li; Robert Sellier; Ulrike Bartz; Michael Gütschow
Journal:  ACS Med Chem Lett       Date:  2014-08-11       Impact factor: 4.345

2.  Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption.

Authors:  Zhong-Yuan Ren; Irma Machuca-Gayet; Chantal Domenget; Rene Buchet; Yuqing Wu; Pierre Jurdic; Saida Mebarek
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

3.  MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L.

Authors:  Xinyu R Ma; Yugendar R Alugubelli; Yuying Ma; Erol C Vatansever; Danielle A Scott; Yuchen Qiao; Ge Yu; Shiqing Xu; Wenshe Ray Liu
Journal:  ChemMedChem       Date:  2021-07-29       Impact factor: 3.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.